Polymer-tetrodotoxin conjugates to induce prolonged duration local anesthesia with minimal toxicity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31189915.
- Also identified by DOI 10.1038/s41467-019-10296-9 and PMC identifier 6561913.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
There is clinical and scientific interest in developing local anesthetics with prolonged durations of effect from single injections. The need for such is highlighted by the current opioid epidemic. Site 1 sodium channel blockers such as tetrodotoxin (TTX) are extremely potent, and can provide very long nerve blocks but the duration is limited by the associated systemic toxicity. Here we report a system where slow release of TTX conjugated to a biocompatible and biodegradable polymer, poly(triol dicarboxylic acid)-co-poly(ethylene glycol) (TDP), is achieved by hydrolysis of ester linkages. Nerve block by the released TTX is enhanced by administration in a carrier with chemical permeation enhancer (CPE) properties. TTX release can be adjusted by tuning the hydrophilicity of the TDP polymer backbone. In vivo, 1.0-80.0 µg of TTX released from these polymers produced a range of durations of nerve block, from several hours to 3 days, with minimal systemic or local toxicity.
Medical subject headings
- Anesthetics, Local
- Drug Carriers
- Nerve Block
- Sodium Channel Blockers
- Tetrodotoxin